Schizophrenia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Schizophrenia stocks.

Schizophrenia Stocks Recent News

Date Stock Title
Apr 15 BMY Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Apr 15 LLY Jim Cramer is Recommending These 10 Stocks in April
Apr 15 BMY In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions
Apr 15 BMY Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
Apr 15 LLY More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm
Apr 14 AZN 4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Apr 13 LLY Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
Apr 13 LLY 3 Magnificent Stocks That Could Double or More by 2030
Apr 12 LLY Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says
Apr 12 LLY Shark Tank's Mark Cuban speaks out on weight-loss drugs
Apr 12 BMY Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12 LLY GLP-1s benefit Parkinson’s: Barclays sees implications across biopharma
Apr 12 AZN AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Apr 12 AZN Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Apr 12 BMY The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Apr 12 LLY European regulator concludes no suicide link to obesity drugs
Apr 12 LLY No link between weight loss drugs and suicidal thoughts, EU regulator concludes
Apr 11 AZN Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
Apr 11 AZN AstraZeneca hit by investor backlash over chief Pascal Soriot’s £19m pay deal
Apr 11 AZN World risks ‘tepid Twenties’ as debt levels and inflation soar, warns IMF
Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

Browse All Tags